Tag Archives: Humanized Monoclonal Antibodies

Bevacizumab enhances the therapeutic efficacy of Irinotecan against human head and neck squamous cell carcinoma xenografts

Cao S, Durrani FA, Toth K, Rustum YM, Seshadri M. Bevacizumab enhances the therapeutic efficacy of Irinotecan against human head and neck squamous cell carcinoma xenografts. Oral Oncol. June 2011;47(6):459-466. Full Text – Open Access Publication Date June 2011 How Analyze was Used “All post processing and analysis were performed using Analyze™ (AnalyzeDirect, Overland Park,…

Quantifying antivascular effects of monoclonal antibodies to vascular endothelial growth factor: insights from imaging

O’Connor JPB, Carano RAD, Clamp AR, Ross J, Ho CCK, Jackson A, Parker GJM, Rose CJ, Peale FV, Friesenhahn M, Mitchell CL, Watson Y, Roberts C, Hope L, Cheung S, Reslan HB, Go MAT, Pacheco GJ, Wu X, Cao TC, Ross S, Buonaccorsi GA, Davies K, Hasan J, Thornton P, del Puerto O, Ferrara N,…

Imaging tumors with an albumin-binding Fab, a novel tumor-targeting agent

Dennis MS, Jin H, Dugger D, Yang R, McFarland L, Ogasawara A, Williams S, Cole MJ, Ross S, Schwall R. Imaging tumors with an albumin-binding Fab, a novel tumor-targeting agent. Cancer Res. January 2007;67(1):254-261. Full Text – Open Access Publication Date January 2007 How Analyze was Used “Images were coregistered by geometric transformation and fused…